Abstract
The antitumor activity of l‐β‐D‐arabinofuranosylcytosine‐5′‐alkylphosphates (CnPCAs) against L1210 leukemia in mice after oral administration was demonstrated. The optimum length of the alkyl group on the phosphate moiety of CnPCA for exhibiting a high antitumor activity was found to be between tetradecyl (C14) and tricosyl (C23). The most active alkyl derivative in this system was found to be l‐β‐D‐arabinofuranosylcytosine‐5′‐stearylphosphate (C18PCA). The optimum and minimum effective doses of C18PCA were 100 and 6,25 mg/kg/day (q1d, day 1 to day 5), respectively. The maximum T/C% of C18PCA was approximately 220. The antitumor activity of C18PCA was not greatly dependent on the treatment schedule and route. Plasma concentration of 1‐β‐D‐arabinofurano‐sylcytosine (ara‐C) remained in the range of 0.4 to 0.75 μmol/ml for 24 h after oral administration of 100 mgAg (170 μmol/kg) of C18PCA. These results indicate that C18PCA administered per orally is absorbed intact through the gastrointestinal tract and ara‐C is released for a long period of time. C18PCA is regarded as an orally active depot form of ara‐C
Keywords: Ara‐C, l‐β‐D‐Arabinofuranosylcytosine‐5′‐stearylphosphate, C18PCA, Oral activity, Pharmacokinetics
Full Text
The Full Text of this article is available as a PDF (390.8 KB).
REFERENCES
- 1. ) Aoshima , M. , Tsukagoshi , S. , Sakurai , Y. , Oh‐ishi , J. , Ishida , T. and Kobayashi , H.Antitumor activities of newly synthesized N4‐acyl‐l‐β‐D‐arabinofuranosylcyto‐sine . Cancer Res. , 36 , 2726 – 2732 ( 1976. ). [PubMed] [Google Scholar]
- 2. ) Aoshima , M. , Tsukagoshi , S. , Sakurai , Y. , Oh‐ishi , J. , Ishida , T. and Kobayashi , H.N4‐Behenoyl‐1‐β‐D‐arabino‐furanosylcytosine as a potential new antitumor agent . Cancer Res. , 37 , 2481 ( 1977. ). [PubMed] [Google Scholar]
- 3. ) Hoshi , A. , Kanzawa , F. and Kuretani , K.Antitumor activity of cyclocytidine in a variety of tumors . Gann , 63 , 353 – 360 ( 1972. ). [PubMed] [Google Scholar]
- 4. ) Hoshi , A. , Kanzawa , F. , Kuretani , K. , Saneyoshi , M. and Arai , Y.2,2′‐OCyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase . Gann , 62 , 145 – 146 ( 1971. ). [PubMed] [Google Scholar]
- 5. ) Neil , G. L. , Moxley , T. E. and Manak , R. C.Enhancement by tetrahydrouridine of 1‐β‐D‐arabinofurano‐sylcytosine (Cytarabine) oral activity in L1210 leukemic mice . Cancer Res. , 30 , 2166 – 2172 ( 1970. ). [PubMed] [Google Scholar]
- 6. ) Kreis , W. , Woodcock , T. M. , Gordon , C. S. and Krakoff , I. H.Tetrahydrouridine: physiologic disposition and effect upon deamination of cytosine arabinoside in man . Cancer Treat. Rep. , 61 , 1347 – 1353 ( 1977. ). [PubMed] [Google Scholar]
- 7. ) Fox , J. J. , Falco , A. E. , Wempen , I. , Pomeroy , D. , Dowling , M. D. and Burchenal , H. J.Oral and parenteral activity of 2,2′‐anhydro‐l‐β‐D‐arabinofuranosyl‐5‐fluorocytosine against both intraperitoneally and intra‐cerebrally inoculated mouse leukemia . Cancer Res. , 32 , 2269 – 2272 ( 1972. ). [PubMed] [Google Scholar]
- 8. ) Wecher , W. J. , Gish , D. T. , Greig , M. E , Gray , G. D. , Moxley , T. E. , Kuenzel , S. L. , Gray , L. G. , Gibbons , A. J. , Griffin , R. L. and Neil , G. L.Nucleic acids. 16. Orally active derivatives of ara‐cytidine . J. Med. Chem. , 19 , 1013 – 1016 ( 1976. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Hori , K. , Tsuruo , T. , Naganuma , K. , Tsukagoshi , S. and Sakurai , Y.Antitumor effects and pharmacology of orally administered N4‐palmitoyl‐ 1‐β‐D‐arabinofuranosylcytosine in mice . Cancer Res. , 44 , 172 – 177 ( 1984. ). [PubMed] [Google Scholar]
- 10. ) Saneyoshi , M. , Morozumi , M. , Kodama , K. , Machida , H. , Kuninaka , A. and Yoshmo , H.Synthetic nucleosides and nucleotides. XVI, Synthesis and biological evaluations, of a series of 1‐β‐D‐arabinofuranosylcytosine 5′‐alkyl or arylphosphates . Chem. Pharm. Bull. , 28 , 2915 – 2923 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Sato , T. , Morozumi , M. , Kodama , K. , Kuninaka , A. and Yoshino , H.Sensitive radioimmunoassay for Cytarabine and uracil arabinoside in plasma . Cancer Treat. Rep. , 11 , 1357 – 1366 ( 1984. ). [PubMed] [Google Scholar]
- 12. ) Evans , J. S. , Musser , E. A. , Bostwick , L. and Mengel , G. D.The effect of 1‐β‐D‐arabinofuranosylcytosine hydrochloride on murine neoplasms . Cancer Res. , 24 , 1285 – 1293 ( 1964. ). [PubMed] [Google Scholar]
- 13. ) Kleine , J. , Tyrer , D. D. , Gang , M. , Venditti , J. M. and Goldin , A.Influence of route of administration on antileukemia activity of cytosine arabinoside (NSC 63878) in advanced leukemia L1210 in mice . Cancer Chemother. Rep. , 52 , 399 – 404 ( 1968. ). [PubMed] [Google Scholar]